GGrantIndex
Sort

141,003 grants matching cytokine

Defining bacterial members of the ocular surface microbiome and assessing stability over time

$1,092,426
Anthony J St Leger · University Of Pittsburgh At Pittsburgh · U24 · FY2025 · EY

Epigenomics of T cells and innate immune cells in human asthma

$1,092,337
Anjana Rao · La Jolla Institute For Immunology · R01 · FY2014 · HL

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

$1,092,161
Jonathan Kil · Sound Pharmaceuticals, Inc. · U01 · FY2022 · TR

Project 1: Panbetacoronavirus vaccines

$1,092,131
Barton F Haynes · Duke University · P01 · FY2023 · AI

Integrated Microfluidic System for Oral Diagnostics

$1,091,537
Sandia Corp-Sandia National Laboratories · U01 · FY2003 · DE

Virus host interactions in clinical samples

$1,091,396
Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Glycolipid Presentation by CD1d

$1,091,369
University Of Chicago · P01 · FY2003 · AI

Sequelae of Hip Fracture in Men: An Epidemiologic Study

$1,091,310
Jay Steven Magaziner · University Of Maryland Baltimore · R37 · FY2006 · AG

AADRC -- Mechanisms of Virus-Induced Asthma

$1,091,250
University Of Wisconsin Madison · P01 · FY2001 · AI

Signaling in the retina and retinal pigment epithelium

$1,091,042
Thomas Redmond · National Eye Institute · ZIA · FY2014 · EY

Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19

$1,090,900
Florence Burleson · · N01 · FY2023 · ES

Immunological mechanism of muscle-localizing self-replicating RNA vaccines

$1,090,789
Taishi Kimura · Hdt Bio Corporation · R01 · FY2025 · AI

Studies of Chemokine-Receptor Interactions with Chemokines and alarmins

$1,090,780
Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,090,698
Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

Vector Production Core

$1,090,470
Norman L Letvin · Duke University · U19 · FY2007 · AI

Linking the physical and chemical characteristics of Qdots to their toxicity

$1,090,146
Terrance J Kavanagh · University Of Washington · U19 · FY2012 · ES

Acne: a disease of lipid metabolism, microbiome and the immune response

$1,089,937
Robert L Modlin · University Of California Los Angeles · P50 · FY2024 · AR

Effects of Multi-Modal Exercise Intervention Post Hip Fracture

$1,089,902
Jay Steven Magaziner · University Of Maryland Baltimore · R37 · FY2017 · AG

NADPH Oxidases as Novel Targets for Cancer Therapy

$1,089,797
James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Role of CEBP transcription factors in regulating cell growth and tumorigenesis

$1,089,789
Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Immune Regulation in Mycobacterial and Fungal Infections

$1,089,788
Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS

$1,089,572
Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

International Tuberculosis Clinical Research

$1,089,343
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Predictors of Pregnancy Outcome in SLE and APS

$1,089,221
Jane E Salmon · Hospital For Special Surgery · R01 · FY2007 · AR

Novel and Optimized Diagnostics for Pediatric TB

$1,088,847
Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI